Wall Street Journal, May 12, 2016. Moves in Congress to link billions of dollars in new medical research funding to revised standards for drug and medical-device approvals are troubling some public-health experts, who say the combination makes it too easy for lawmakers to support lower patient-safety standards.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Big Money Stem-Cell Therapy Push Raises Concerns
Politico, April 29, 2016. We explain why the REGROW Act is an effort to short-circuit the FDA’s “gold standard” for drug approvals and why it shows “a lack of understanding of the importance of well-designed research.”
Read More »Safety Groups Urge Government to Recall Ikea Dresser
Consumer Reports, April 27, 2016. Three deaths from falling furniture prompt urgent call for action from Consumer Reports and its partners.
Read More »Kids with ADHD Do Better with Therapy First, Study Finds
NBC News, April 27, 2016. National Center for Health Research weighs in on behavioral training programs for children with ADHD.
Read More »FDA Panel Votes Against Sarepta’s Drug for Duchenne Muscular Dystrophy
STAT, April 25, 2016. A federal advisory panel voted Monday that a drug from Sarepta Therapeutics was not effective for treating Duchenne muscular dystrophy, a rare and fatal muscle-wasting disease. About 13,000 children, mostly boys, are afflicted.
Read More »